<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02266004</url>
  </required_header>
  <id_info>
    <org_study_id>20140127</org_study_id>
    <nct_id>NCT02266004</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Stimulation for Freezing of Gait</brief_title>
  <acronym>TDCS-FOG</acronym>
  <official_title>Transcranial Direct Current Stimulation for Freezing of Gait in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effects of transcranial direct current stimulation (tDCS) in
      combination with locomotor training in patients with Parkinson's disease (PD) and freezing of
      gait (FOG).
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    difficult to recruit participants
  </why_stopped>
  <start_date type="Actual">September 12, 2014</start_date>
  <completion_date type="Actual">June 27, 2018</completion_date>
  <primary_completion_date type="Actual">June 27, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Walking Speed</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>walking speed will be measured using sensors during a 90 second walk</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Motor Scores as Measured by Unified Parkinson's Disease Rating Scale (UPDRS)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>UPDRS motor score range from 0-56 with higher scores indicating greater impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Stride Length</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Stride length is measured with mobile sensors attached to participant's extremities during the 90 second walk.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Postural Sway</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Postural sway is measured with mobile sensors attached to participant's extremities during the 30 seconds of quiet standing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Timed Up-and-Go (TUG) Time</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Participants are timed while standing up from a chair, walking around a cone, and returning to their chair.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Motor Threshold</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Transcranial magnetic stimulation is used to measure motor threshold of the primary motor area. The motor threshold was defined as the minimum intensity needed to evoke 5 out 10 motor evoked potentials in the first dorsal interosseous muscle in the hand.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Glutamate/Gamma Aminobutyric Acid(GABA) Ratio</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Glutamate/GABA ratio will be measured with magnetic Resonance Spectroscopy (MRS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Backward Digit Span</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Digit span is measured by total number of correct digits recited.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Trail Making Test Time</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>Trail making test is measured as the number of seconds required to complete the task, with higher scores indicating greater impairment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Montreal Cognitive Assessment (MOCA)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>The MOCA has a total score ranging from 0-30 with a higher score indicating better performance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Auditory Consonant Trigrams Test (ACT)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>The ACT has a score from 0-60 with higher score indicating better performance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the Freezing of Gait Questionnaire (FOG-Q)</measure>
    <time_frame>baseline, 3 weeks</time_frame>
    <description>The FOG-Q has a total score ranging from 0-24 with higher scores indicating more incidents of freezing.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">9</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>tDCS+ LT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation (tDCS)</intervention_name>
    <description>Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.</description>
    <arm_group_label>tDCS+ LT</arm_group_label>
    <other_name>tDCS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>locomotor training</intervention_name>
    <description>An individualized dual-task walking program for approximately 30 minutes.</description>
    <arm_group_label>tDCS+ LT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age 18- 80

          2. Parkinson's disease stages 2-3 Hoehn and Yahr.

          3. Presence of Freezing of Gait

          4. Stable medication regimen

          5. Time to complete TUG &gt;12 seconds

        Exclusion Criteria:

          1. medical condition that would interfere with walking and training for 30 minutes

          2. unable to perform timed up and go in the off condition

          3. history of seizures

          4. implanted deep brain stimulator, pacemaker or any other electronic device.

          5. dementia

          6. Adults unable to consent, individuals who are not yet adults (infants, children,
             teenagers) pregnant women, prisoners will not be considered for participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Corneliu Luca, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 7, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2014</study_first_posted>
  <results_first_submitted>May 28, 2020</results_first_submitted>
  <results_first_submitted_qc>May 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 16, 2020</results_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Corneliu C Luca</investigator_full_name>
    <investigator_title>Assisstant Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>neuromodulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 2, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/04/NCT02266004/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>One participant was removed from the study and re-enrolled. However, this participant did not complete the study intervention on their first or second enrollment. Therefore their data has not been included in any of the outcome measures.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>tDCS+ LT</title>
          <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>unrelated adverse event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>tDCS+ LT</title>
          <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.4" spread="9.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Walking Speed</title>
        <description>walking speed will be measured using sensors during a 90 second walk</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>Unable to retrieve collected data on the other 5 participants who completed the study due to a malfunction in the sensors.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Walking Speed</title>
          <description>walking speed will be measured using sensors during a 90 second walk</description>
          <population>Unable to retrieve collected data on the other 5 participants who completed the study due to a malfunction in the sensors.</population>
          <units>m/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.169" spread="0.244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Motor Scores as Measured by Unified Parkinson's Disease Rating Scale (UPDRS)</title>
        <description>UPDRS motor score range from 0-56 with higher scores indicating greater impairment.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Motor Scores as Measured by Unified Parkinson's Disease Rating Scale (UPDRS)</title>
          <description>UPDRS motor score range from 0-56 with higher scores indicating greater impairment.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.714" spread="14.088"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Stride Length</title>
        <description>Stride length is measured with mobile sensors attached to participant's extremities during the 90 second walk.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>Unable to retrieve collected data on the other 5 participants who completed the study due to a malfunction in the sensors.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Stride Length</title>
          <description>Stride length is measured with mobile sensors attached to participant's extremities during the 90 second walk.</description>
          <population>Unable to retrieve collected data on the other 5 participants who completed the study due to a malfunction in the sensors.</population>
          <units>m</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.127" spread="0.239"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Postural Sway</title>
        <description>Postural sway is measured with mobile sensors attached to participant's extremities during the 30 seconds of quiet standing.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Postural Sway</title>
          <description>Postural sway is measured with mobile sensors attached to participant's extremities during the 30 seconds of quiet standing.</description>
          <units>m^2/s^5</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.012" spread="0.009"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Timed Up-and-Go (TUG) Time</title>
        <description>Participants are timed while standing up from a chair, walking around a cone, and returning to their chair.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Timed Up-and-Go (TUG) Time</title>
          <description>Participants are timed while standing up from a chair, walking around a cone, and returning to their chair.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.878" spread="4.268"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Motor Threshold</title>
        <description>Transcranial magnetic stimulation is used to measure motor threshold of the primary motor area. The motor threshold was defined as the minimum intensity needed to evoke 5 out 10 motor evoked potentials in the first dorsal interosseous muscle in the hand.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>3-week data not collected for 5 participants who completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Motor Threshold</title>
          <description>Transcranial magnetic stimulation is used to measure motor threshold of the primary motor area. The motor threshold was defined as the minimum intensity needed to evoke 5 out 10 motor evoked potentials in the first dorsal interosseous muscle in the hand.</description>
          <population>3-week data not collected for 5 participants who completed the study.</population>
          <units>percentage of TMS output</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.005" spread="0.021"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Glutamate/Gamma Aminobutyric Acid(GABA) Ratio</title>
        <description>Glutamate/GABA ratio will be measured with magnetic Resonance Spectroscopy (MRS).</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>No data was collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glutamate/Gamma Aminobutyric Acid(GABA) Ratio</title>
          <description>Glutamate/GABA ratio will be measured with magnetic Resonance Spectroscopy (MRS).</description>
          <population>No data was collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Backward Digit Span</title>
        <description>Digit span is measured by total number of correct digits recited.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>No data was collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Backward Digit Span</title>
          <description>Digit span is measured by total number of correct digits recited.</description>
          <population>No data was collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Trail Making Test Time</title>
        <description>Trail making test is measured as the number of seconds required to complete the task, with higher scores indicating greater impairment.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>No data was collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Trail Making Test Time</title>
          <description>Trail making test is measured as the number of seconds required to complete the task, with higher scores indicating greater impairment.</description>
          <population>No data was collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Montreal Cognitive Assessment (MOCA)</title>
        <description>The MOCA has a total score ranging from 0-30 with a higher score indicating better performance.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Montreal Cognitive Assessment (MOCA)</title>
          <description>The MOCA has a total score ranging from 0-30 with a higher score indicating better performance.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.57" spread="1.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Auditory Consonant Trigrams Test (ACT)</title>
        <description>The ACT has a score from 0-60 with higher score indicating better performance.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <population>No data was collected for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Auditory Consonant Trigrams Test (ACT)</title>
          <description>The ACT has a score from 0-60 with higher score indicating better performance.</description>
          <population>No data was collected for this outcome measure.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in the Freezing of Gait Questionnaire (FOG-Q)</title>
        <description>The FOG-Q has a total score ranging from 0-24 with higher scores indicating more incidents of freezing.</description>
        <time_frame>baseline, 3 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>tDCS+ LT</title>
            <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in the Freezing of Gait Questionnaire (FOG-Q)</title>
          <description>The FOG-Q has a total score ranging from 0-24 with higher scores indicating more incidents of freezing.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.29" spread="3.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>tDCS+ LT</title>
          <description>Transcranial direct current stimulation(tDCS) plus locomotor training (LT) 3x per week for 3 consecutive weeks.
Transcranial Direct Current Stimulation (tDCS): Anodal tDCS will be applied for the duration of the walking training at 2 milliamps with IOMED Phoresor.
locomotor training: An individualized dual-task walking program for approximately 30 minutes.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>fall at home</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="9"/>
              </event>
              <event>
                <sub_title>fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="9"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Data was not collected on 4 of the outcome measures due to lack of funding which contributed to the difficulty in performing the tests required per protocol.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Corneliu Luca, MD</name_or_title>
      <organization>University of Miami</organization>
      <phone>305-243-6732</phone>
      <email>cluca@med.miami.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

